FDAsafety guidance83% confidence
Drug Trials Snapshots
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to AbbVie.
Regulatory Analysis
Drug Trials Snapshots: breaking down the what, how and why. Drug Trials Snapshots are part of an overall FDA effort to make demographic data more available and transparent.
Supporting Context
- Therapeutic area
- Not specified
- Sub-indication
- General
Related signal: Phase 1 Study of ABBV-722 Shows Focus on Safety and Pharmacokinetics